News
)
Oxford Nanopore, Yemaachi Biotech, and Global Partners Collaborate to Improve Childhood Leukemia Outcomes in Ghana
- Population genomics
- Cancer research
- Clinical
- Human genomics
- High-throughput
- Structural variation
September 9 2024
)
Oxford Nanopore and UK Biobank to create world's first epigenetic dataset targeting the causes of cancer, dementia, complex disease | Oxford Nanopore Technologies
- Population genomics
- Epigenetics
- Clinical research
- Direct analysis
- High-throughput
- Human genomics
November 27 2024